The market for treatments for dementia was valued at USD 13,459.39 million in 2021, growing at a CAGR of 8.28% during the anticipated period 2022 - 2027. The market for dementia medications is anticipated to be significantly impacted by theCOVID-19 pandemic outbreak. The market for dementia drugs is likely to grow as a result of the ageing population suffering from a variety of disorders and the rising prevalence of target disorders. The increasing incidence of dementia cases is one of the main factors influencing the global market for drugs to treat it. Alzheimer's Disease International estimates that there will be more than50 million dementia sufferers worldwide in 2020. This number is anticipated to double every 20 years, rising to 82 million in 2030 and 152 million in 2050.
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
